160 related articles for article (PubMed ID: 33938370)
1. Serum catestatin level is increased in women with preeclampsia.
Tüten N; Güralp O; Gök K; Hamzaoglu K; Oner YO; Makul M; Bulut H; Irmak K; Tüten A; Malik E
J Obstet Gynaecol; 2022 Jan; 42(1):55-60. PubMed ID: 33938370
[TBL] [Abstract][Full Text] [Related]
2. Serum Vasostatin-1 Level is Increased in Women with Preeclampsia.
Tüten A; Tüten N; Gök K; Hamzaoglu K; Bulut H; Malik E; Guralp O
Z Geburtshilfe Neonatol; 2022 Jun; 226(3):178-185. PubMed ID: 35181881
[TBL] [Abstract][Full Text] [Related]
3. Serum neprilysin levels are elevated in preeclampsia.
Tüten N; Malik E; Gök K; Hamzaoglu K; Makul M; Öner YÖ; Bulut H; Tüten A; Güralp O
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):869-873. PubMed ID: 34507663
[TBL] [Abstract][Full Text] [Related]
4. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
Qin W; Zhan Y; Ye YH; Li C; Cui XN
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
[TBL] [Abstract][Full Text] [Related]
5. Catestatin serum levels are increased in male patients with obstructive sleep apnea.
Borovac JA; Dogas Z; Supe-Domic D; Galic T; Bozic J
Sleep Breath; 2019 Jun; 23(2):473-481. PubMed ID: 30088239
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy.
Bralewska M; Biesiada L; Grzesiak M; Rybak-Krzyszkowska M; Huras H; Gach A; Pietrucha T; Sakowicz A
BMC Pregnancy Childbirth; 2021 Oct; 21(1):680. PubMed ID: 34620125
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
[TBL] [Abstract][Full Text] [Related]
8. Catestatin-A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies.
Palmrich P; Schirwani-Hartl N; Haberl C; Haslinger P; Heinzl F; Zeisler H; Binder J
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762872
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum human pregnancy-specific beta-1-glycoprotein 1 levels in pregnant women with or without preeclampsia.
Temur M; Serpim G; Tuzluoğlu S; Taşgöz FN; Şahin E; Üstünyurt E
J Obstet Gynaecol; 2020 Nov; 40(8):1074-1078. PubMed ID: 31790616
[TBL] [Abstract][Full Text] [Related]
10. The role of cystatin C, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the evaluation of kidney function in women with preeclampsia.
Taşkömür AT; Erten Ö
Taiwan J Obstet Gynecol; 2021 Jul; 60(4):615-620. PubMed ID: 34247797
[TBL] [Abstract][Full Text] [Related]
11. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery.
Powers RW; Bodnar LM; Ness RB; Cooper KM; Gallaher MJ; Frank MP; Daftary AR; Roberts JM
Am J Obstet Gynecol; 2006 Jan; 194(1):160. PubMed ID: 16389026
[TBL] [Abstract][Full Text] [Related]
12. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure.
Mahapatra NR
Cardiovasc Res; 2008 Dec; 80(3):330-8. PubMed ID: 18541522
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide production is not altered in preeclampsia.
Diejomaoh FM; Omu AE; Al-Busiri N; Taher S; Al-Othman S; Fatinikun T; Fernandes S
Arch Gynecol Obstet; 2004 May; 269(4):237-43. PubMed ID: 15221318
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
15. Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia.
Bayhan G; Atamer Y; Atamer A; Yokus B; Baylan Y
Clin Exp Obstet Gynecol; 2000; 27(2):142-6. PubMed ID: 10968357
[TBL] [Abstract][Full Text] [Related]
16. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
[TBL] [Abstract][Full Text] [Related]
17. Serum catestatin concentrations are decreased in obese children and adolescents.
Simunovic M; Supe-Domic D; Karin Z; Degoricija M; Paradzik M; Bozic J; Unic I; Skrabic V
Pediatr Diabetes; 2019 Aug; 20(5):549-555. PubMed ID: 30714297
[TBL] [Abstract][Full Text] [Related]
18. Serum calcium, urea and uric acid levels in pre-eclampsia.
Hassan TJ; Sadaruddin A; Jafarey SN
J Pak Med Assoc; 1991 Aug; 41(8):183-5. PubMed ID: 1942478
[TBL] [Abstract][Full Text] [Related]
19. Relation between serum uric acid and plasma adenosine levels in women with preeclampsia.
Suzuki S; Yoneyama Y; Sawa R; Otsubo Y; Takeuchi T; Araki T
Gynecol Obstet Invest; 2001; 51(3):169-72. PubMed ID: 11306903
[TBL] [Abstract][Full Text] [Related]
20. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
J Hypertens; 2002 Jul; 20(7):1335-45. PubMed ID: 12131530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
